<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34853325</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>The effects of molecular crowding and CpG hypermethylation on DNA G-quadruplexes formed by the C9orf72 nucleotide repeat expansion.</ArticleTitle><Pagination><StartPage>23213</StartPage><MedlinePgn>23213</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">23213</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-02041-4</ELocationID><Abstract><AbstractText>A nucleotide repeat expansion (NRE), (G<sub>4</sub>C<sub>2</sub>)<sub>n</sub>, located in a classically noncoding region of C9orf72 (C9), is the most common genetic mutation associated with ALS/FTD. There is increasing evidence that nucleic acid structures formed by the C9-NRE may both contribute to ALS/FTD, and serve as therapeutic targets, but there is limited characterization of these nucleic acid structures under physiologically and disease relevant conditions. Here we show in vitro that the C9-NRE DNA can form both parallel and antiparallel DNA G-quadruplex (GQ) topological structures and that the structural preference of these DNA GQs can be dependent on the molecular crowding conditions. Additionally, 5-methylcytosine DNA hypermethylation, which is observed in the C9-NRE locus in some patients, has minimal effects on GQ topological preferences. Finally, molecular dynamic simulations of methylated and nonmethylated GQ structures support in vitro data showing that DNA GQ structures formed by the C9-NRE DNA are stable, with structural fluctuations limited to the cytosine-containing loop regions. These findings provide new insight into the structural polymorphic preferences and stability of DNA GQs formed by the C9-NRE in both the methylated and nonmethylated states, as well as reveal important features to guide the development of upstream therapeutic approaches to potentially attenuate C9-NRE-linked diseases.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ozcan</LastName><ForeName>Kadir A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghaffari</LastName><ForeName>Layla T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haeusler</LastName><ForeName>Aaron R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, USA. Aaron.Haeusler@jefferson.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Jefferson Weinberg ALS Center, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, 900 Walnut Street, JHN suite 410, Philadelphia, PA, 19107, USA. Aaron.Haeusler@jefferson.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R00 NS091486</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS116761</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD017987</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>S10 OD023479</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="Y">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054856" MajorTopicYN="Y">G-Quadruplexes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34853325</ArticleId><ArticleId IdType="pmc">PMC8636472</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-02041-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-02041-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton AE, et al. A Hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386:1672&#x2013;1682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5970949</ArticleId><ArticleId IdType="pubmed">26595641</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur. J. Neurol. 2020;27:1918&#x2013;1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, et al. C9ORF72 hexanucleotide repeat expansions in patients with ALS from the Coriell Cell Repository. Neurology. 2012;79:482&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3467648</ArticleId><ArticleId IdType="pubmed">22815561</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, et al. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol. Aging. 2012;33(2950):e2955&#x2013;2950.e2957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617405</ArticleId><ArticleId IdType="pubmed">22840558</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, et al. Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72. Acta Neuropathol. 2015;130:863&#x2013;876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4655160</ArticleId><ArticleId IdType="pubmed">26437865</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126:881&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T, et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U. S. A. 2013;110:E4968&#x2013;4977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat. Rev. Neurosci. 2016;17:383&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Nana AL, Yokoyama JS, Seeley WW. C9orf72-FTD/ALS pathogenesis: Evidence from human neuropathological studies. Acta Neuropathol. 2019;137:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayl K, Shaw CE, Lee YB. Disease mechanisms and therapeutic approaches in C9orf72 ALS-FTD. Biomedicines. 2021;9:601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8229688</ArticleId><ArticleId IdType="pubmed">34070550</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, et al. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z, et al. Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Neuron. 2014;83:1043&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4232217</ArticleId><ArticleId IdType="pubmed">25132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel RS, et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: A phase 2, open-label, dose-escalation study. The Lancet. 2016;388:3017&#x2013;3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">27939059</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R, et al. G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo. EMBO Mol. Med. 2018;10:22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760849</ArticleId><ArticleId IdType="pubmed">29113975</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrank Z, et al. Oligonucleotides Targeting Telomeres and Telomerase in Cancer. Molecules. 2018;23:2267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6225148</ArticleId><ArticleId IdType="pubmed">30189661</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta A, Ganguly A, Chowdhury S. Promise of G-quadruplex structure binding ligands as epigenetic modifiers with anti-cancer effects. Molecules. 2019;24:582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6384772</ArticleId><ArticleId IdType="pubmed">30736345</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen-Petersen BL, Sears RC. Mission possible: Advances in MYC therapeutic targeting in cancer. BioDrugs. 2019;119:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6790341</ArticleId><ArticleId IdType="pubmed">31392631</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamori M, et al. A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo. Nat. Genet. 2020;12:3359&#x2013;3159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7043212</ArticleId><ArticleId IdType="pubmed">32060489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V, Kashav T, Islam A, Ahmad F, Hassan MI. Structural insight into C9orf72 hexanucleotide repeat expansions: Towards new therapeutic targets in FTD-ALS. Neurochem. Int. 2016;100:11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">27539655</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamitsu S, et al. Perspectives for applying G-quadruplex structures in neurobiology and neuropharmacology. Int. J. Mol. Sci. 2019;20:2815&#x2013;2884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6627371</ArticleId><ArticleId IdType="pubmed">31200506</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamitsu S, Yabuki Y, Ikenoshita S, Wada T, Shioda N. Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrins. Biochem. Biophys. Res. Commun. 2020;531:51&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">31980177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri B, Mirceta M, Bomsztyk K, Macgregor RB, Pearson CE. Quadruplex formation by both G-rich and C-rich DNA strands of the C9orf72 (GGGGCC)8&#xb7;(GGCCCC)8 repeat: Effect of CpG methylation. Nucleic Acids Res. 2015;43:10055&#x2013;10064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4787773</ArticleId><ArticleId IdType="pubmed">26432832</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, Liu C, Geng Y, Zhu G. Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD. Sci. Rep. 2015;5:16673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643247</ArticleId><ArticleId IdType="pubmed">26564809</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng Y, et al. Crystal structure of parallel G-quadruplex formed by the two-repeat ALS- and FTD-related GGGGCC sequence. Nucleic Acids Res. 2021;49:5881&#x2013;5890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8191786</ArticleId><ArticleId IdType="pubmed">34048588</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#x10d;i&#x107; J, Plavec J. Solution structure of a DNA quadruplex containing ALS and FTD related GGGGCC repeat stabilized by 8-bromodeoxyguanosine substitution. Nucleic Acids Res. 2015;43:8590&#x2013;8600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4787828</ArticleId><ArticleId IdType="pubmed">26253741</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppert JL. Four-stranded nucleic acids: Structure, function and targeting of G-quadruplexes. Chem. Soc. Rev. 2008;37:1375.</Citation><ArticleIdList><ArticleId IdType="pubmed">18568163</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu EY, et al. C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. Acta Neuropathol. 2014;128(525&#x2013;541):4161616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4161616</ArticleId><ArticleId IdType="pubmed">24806409</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ J, et al. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 2015;129(39&#x2013;52):4282973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4282973</ArticleId><ArticleId IdType="pubmed">25388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z, et al. The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol. 2015;129:715&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pubmed">25716178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Roland C, Sagui C. Structural and dynamical characterization of DNA and RNA quadruplexes obtained from the GGGGCC and GGGCCT hexanucleotide repeats associated with C9FTD/ALS and SCA36 diseases. ACS Chem. Neurosci. 2017;9:1104&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6442734</ArticleId><ArticleId IdType="pubmed">29281254</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng K-W, Chen Z, Hao Y-H, Tan Z. Molecular crowding creates an essential environment for the formation of stable G-quadruplexes in long double-stranded DNA. Nucleic Acids Res. 2009;38:327&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2800236</ArticleId><ArticleId IdType="pubmed">19858105</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JH, Kim JH, Kim SK, Jang YJ. Conformational change of a G-quadruplex under molecular crowding conditions. J. Biomol. Struct. Dyn. 2019;38:2575&#x2013;2581.</Citation><ArticleIdList><ArticleId IdType="pubmed">31476952</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalihal AP, et al. Hyperosmotic phase separation: Condensates beyond inclusions, granules and organelles. J. Biol. Chem. 2021;296:100044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948973</ArticleId><ArticleId IdType="pubmed">33168632</ArticleId></ArticleIdList></Reference><Reference><Citation>Buscaglia R, et al. Polyethylene glycol binding alters human telomere G-quadruplex structure by conformational selection. Nucleic Acids Res. 2013;41:7934&#x2013;7946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763525</ArticleId><ArticleId IdType="pubmed">23804761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel R, Lohr F, Trantirek L, Dotsch V. High-resolution insight into G-overhang architecture. J. Am. Chem. Soc. 2013;135:2816&#x2013;2824.</Citation><ArticleIdList><ArticleId IdType="pubmed">23339582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansel R, et al. The parallel G-quadruplex structure of vertebrate telomeric repeat sequences is not the preferred folding topology under physiological conditions. Nucleic Acids Res. 2011;39:5768&#x2013;5775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3141269</ArticleId><ArticleId IdType="pubmed">21450807</ArticleId></ArticleIdList></Reference><Reference><Citation>Giesselmann P, et al. Analysis of short tandem repeat expansions and their methylation state with nanopore sequencing. Nat. Biotechnol. 2019;37:1478&#x2013;1481.</Citation><ArticleIdList><ArticleId IdType="pubmed">31740840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B, et al. Characterizations of distinct parallel and antiparallel G-quadruplexes formed by two-repeat ALS and FTD related GGGGCC sequence. Sci. Rep. 2018;8:2366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5799222</ArticleId><ArticleId IdType="pubmed">29402965</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes D, Lipps HJ. G-quadruplexes and their regulatory roles in biology. Nucleic Acids Res. 2015;43:8627&#x2013;8637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4605312</ArticleId><ArticleId IdType="pubmed">26350216</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppert JL, Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res. 2005;33:2908&#x2013;2916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1140081</ArticleId><ArticleId IdType="pubmed">15914667</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsico G, et al. Whole genome experimental maps of DNA G-quadruplexes in multiple species. Nucleic Acids Res. 2019;47:3862&#x2013;3874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6486626</ArticleId><ArticleId IdType="pubmed">30892612</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nsel-Hertsch R, et al. G-quadruplex structures mark human regulatory chromatin. Nat. Genet. 2016;48:1267&#x2013;1272.</Citation><ArticleIdList><ArticleId IdType="pubmed">27618450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao S-Q, et al. DNA G-quadruplex structures mold the DNA methylome. Nat. Struct. Mol. Biol. 2018;25:951&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6173298</ArticleId><ArticleId IdType="pubmed">30275516</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiegel J, et al. G-quadruplexes are transcription factor binding hubs in human chromatin. Genome Biol. 2021;22:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063395</ArticleId><ArticleId IdType="pubmed">33892767</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamitsu S, et al. Identification and immunohistochemical characterization of G-quadruplexes in mouse brain. Biochem. Biophys. Res. Commun. 2020;531:67&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">32035619</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E, Thombre R, Shah Y, Latanich R, Wang J. G-Quadruplexes as pathogenic drivers in neurodegenerative disorders. Nucleic Acids Res. 2021;49:4816&#x2013;4830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8136783</ArticleId><ArticleId IdType="pubmed">33784396</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave JW, Willis DE. G-Quadruplex regulation of neural gene expression. FEBS J. 2021 doi: 10.1111/febs.15900.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15900</ArticleId><ArticleId IdType="pubmed">33905176</ArticleId></ArticleIdList></Reference><Reference><Citation>Zbinden A, Perez-Berlanga M, De Rossi P, Polymenidou M. Phase separation and neurodegenerative diseases: A disturbance in the force. Dev. Cell. 2020;55:45&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">33049211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimura M, et al. Quadruplex folding promotes the condensation of linker histones and DNAs via liquid-liquid phase separation. J. Am. Chem. Soc. 2021;143:9849&#x2013;9857.</Citation><ArticleIdList><ArticleId IdType="pubmed">34152774</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A, Vale RD. RNA phase transitions in repeat expansion disorders. Nature. 2017;546:243&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5555642</ArticleId><ArticleId IdType="pubmed">28562589</ArticleId></ArticleIdList></Reference><Reference><Citation>Fay MM, Anderson PJ, Ivanov P. ALS/FTD-associated C9ORF72 repeat RNA promotes phase transitions in vitro and in cells. Cell Rep. 2017;21:3573&#x2013;3584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5741101</ArticleId><ArticleId IdType="pubmed">29262335</ArticleId></ArticleIdList></Reference><Reference><Citation>Thys RG, Wang YH. DNA replication dynamics of the GGGGCC repeat of the C9orf72 gene. J. Biol. Chem. 2015;290:28953&#x2013;28962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4661408</ArticleId><ArticleId IdType="pubmed">26463209</ArticleId></ArticleIdList></Reference><Reference><Citation>Francois M, Leifert WR, Tellam R, Fenech MF. Folate deficiency and DNA-methyltransferase inhibition modulate G-quadruplex frequency. Mutagenesis. 2016;31:409&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">26758645</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieger E, Vriend G. YASARA View: Molecular graphics for all devices&#x2014;from smartphones to workstations. Bioinformatics. 2014;30:2981&#x2013;2982.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4184264</ArticleId><ArticleId IdType="pubmed">24996895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakalian A, Jack DB, Bayly CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 2002;23:1623&#x2013;1641.</Citation><ArticleIdList><ArticleId IdType="pubmed">12395429</ArticleId></ArticleIdList></Reference><Reference><Citation>Galindo-Murillo R, et al. Assessing the current state of amber force field modifications for DNA. J. Chem. Theory Comput. 2016;12:4114&#x2013;4127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4980684</ArticleId><ArticleId IdType="pubmed">27300587</ArticleId></ArticleIdList></Reference><Reference><Citation>Machireddy B, Kalra G, Jonnalagadda S, Ramanujachary K, Wu C. Probing the binding pathway of BRACO19 to a parallel-stranded human telomeric G-quadruplex using molecular dynamics binding simulation with AMBER DNA OL15 and ligand GAFF2 force fields. J. Chem. Inf. Model. 2017;57:2846&#x2013;2864.</Citation><ArticleIdList><ArticleId IdType="pubmed">29028340</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam B, et al. Stability of two-quartet G-quadruplexes and their dimers in atomistic simulations. J. Chem. Theory Comput. 2020;16:3447&#x2013;3463.</Citation><ArticleIdList><ArticleId IdType="pubmed">32163706</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadlbauer P, et al. Parallel G-triplexes and G-hairpins as potential transitory ensembles in the folding of parallel-stranded DNA G-Quadruplexes. Nucleic Acids Res. 2019;47:7276&#x2013;7293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6698752</ArticleId><ArticleId IdType="pubmed">31318975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz de Luzuriaga I, Lopez X, Gil A. Learning to model G-Quadruplexes: Current methods and perspectives. Annu. Rev. Biophys. 2021;50:209&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">33561349</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunenberg J, Barone G, Spinello A. The right answer for the right electrostatics: Force field methods are able to describe RElative energies of DNA guanine quadruplexes. J. Chem. Theory Comput. 2014;10:2901&#x2013;2905.</Citation><ArticleIdList><ArticleId IdType="pubmed">26588265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>